These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24268788)

  • 1. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation.
    Smith GL; Jiang J; Buchholz TA; Xu Y; Hoffman KE; Giordano SH; Hunt KK; Smith BD
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):274-84. PubMed ID: 24268788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer.
    Smith GL; Xu Y; Buchholz TA; Giordano SH; Jiang J; Shih YC; Smith BD
    JAMA; 2012 May; 307(17):1827-37. PubMed ID: 22550197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up.
    Perera F; Yu E; Engel J; Holliday R; Scott L; Chisela F; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1239-46. PubMed ID: 14630257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer.
    Huo J; Giordano SH; Smith BD; Shaitelman SF; Smith GL
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):709-18. PubMed ID: 26972643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
    J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
    Haque W; Verma V; Haque A; Butler EB; Teh BS
    Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.
    Arthur DW; Koo D; Zwicker RD; Tong S; Bear HD; Kaplan BJ; Kavanagh BD; Warwicke LA; Holdford D; Amir C; Archer KJ; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):681-9. PubMed ID: 12788173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
    Fisher B; Costantino J; Redmond C; Fisher E; Margolese R; Dimitrov N; Wolmark N; Wickerham DL; Deutsch M; Ore L
    N Engl J Med; 1993 Jun; 328(22):1581-6. PubMed ID: 8292119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
    Leonardi MC; Corrao G; Frassoni S; Vingiani A; Dicuonzo S; Lazzeroni M; Fodor C; Morra A; Gerardi MA; Rojas DP; Dell'Acqua V; Marvaso G; Bassi FD; Galimberti VE; Veronesi P; Miglietta E; Cattani F; Zurrida S; Bagnardi V; Viale G; Orecchia R; Jereczek-Fossa BA
    Radiother Oncol; 2019 Apr; 133():68-76. PubMed ID: 30935584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
    Trombetta M; Hall M; Julian TB
    Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and Outcomes of Breast Brachytherapy in Younger Women.
    Smith GL; Huo J; Giordano SH; Hunt KK; Buchholz TA; Smith BD
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):91-101. PubMed ID: 26279027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.